Exercise training for COPD: Physiological basis and results;Le réentraînement à l'effort des BPCO: Bases physiologiques et résultats

Revue des Maladies Respiratoires

Volumn 21, Issue 2 PART 1, 2004, Pages 319-327

  Troosters, T ^a   Gayan Ramirez, G ^b   Pitta, F ^b   Gosselin, N ^b   Gosselink, R ^b   Decramer, M ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

COPD; Emphysema; Muscle; Muscle Weakness; Pulmonary; Rehabilitation

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EMPHYSEMA; ENDURANCE; EXERCISE; FATIGUE; HEALTH STATUS; HUMAN; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; PHYSICAL CAPACITY; QUALITY OF LIFE;

EID: 3042805165     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71289-9     Document Type: Article

References (90)

1. Piperno D, Huchon G, Pribil C, Boucot I, Similowski T: The burden of COPD in France: results from the Confronting COPD survey. Respir Med 2003; 97 Suppl C: S33-S42.
2. Ramsey SD, Sullivan SD: The burden of illness and economic evaluation for COPD. Eur Respir J 2003; Suppl 41: 29s-35s.
3. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE: Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003; 348: 2092-102.
4. Simonds AK: Ethics and decision making in end stage lung disease. Thorax 2003; 58: 272.
5. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM: Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-5.
6. Spencer SP, Calverley M, Sherwood BP, Jones PW: Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 122-8.
7. Reid MB: COPD as a muscle disease. Am J Respir Crit Care Med 2001; 164: 1101-5.
8. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F: Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 809-13.
9. Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-80.
10. Decramer M, Gosselink R, Troosters T, Schepers R: Peripheral muscle force is a determinant of survival in COPD. Eur Respir J 1998; 12: 261S.
11. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G: Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10: 417-23.
12. Sin D, McAlister F, Man S, Anthonisen N: Contemporary management of chronic obstructive pulmonary disease: scientific review JAMA 2003; 290: 2301-12.
13. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J, Lonescu AA: Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355: 362-8.
14. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA: Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001; 56: 779-84.
15. Donner CF, Decramer M: Pulmonary Rehabilitation. Eur Respir Monograph 2000; 13: 1-200.
16. No author. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1-40.
17. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-34.
18. Orozco-Levi M, Gea J, Lloreta JL, Felez M, Minguella J, Serrano S, Broquetas JM: Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 371-8.
19. Levine S, Kaiser L, Leferovich J, Tikunov B: Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337: 1799-806.
20. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J: Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 2001; 17: 939-45.
21. Gosker HR, Engelen MP, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EF, Schols AM: Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002; 76: 113-9.
22. Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X: Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 485-9.
23. Allen DL, Linderman JK, Roy RR, Bigbee AJ, Grindeland RE, Mukku V, Edgerton VR: Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol 1997; 273: C579-C587.
24. Alway SE, Martyn JK, Ouyang J, Chaudhrai A, Murlasits ZS: Id2 expression during apoptosis and satellite cell activation in unloaded and loaded quail skeletal muscles. Am J Physiol Regul Integr Comp Physiol 2003; 284: R540-R549.
25. Smith HK, Maxwell L, Martyn JA, Bass JJ: Nuclear DNA fragmentation and morphological alterations in adult rabbit skeletal muscle after short-term immobilization. Cell Tissue Res 2000; 302: 235-41.
26. Decramer M, De Bock V, Dom R: Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-64.
27. Gosselin N, Matecki S, Poulain M, Ramonatxo M, Ceugniet F, Prefaut C, Varray A: Electrophysiologic changes during exercise testing in patients with chronic obstructive pulmonary disease. Muscle Nerve 2003; 27: 170-9.
28. Troosters T, Gosselink R, Decramer M: Reliability of hand held myometry to measure peripheral muscle strength in COPD. Eur Respir J 1999; 14: 481S.
29. Gosselink R, Troosters T, Decramer M: Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2000; 20: 353-60.
30. Decramer M, Lacquet LM, Fagard R, Rogiers P: Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994; 150: 11-6.
31. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S: Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985; 66: 69-74.
32. Andrews AW, Thomas MW, Bohannon RW: Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther 1996; 76: 248-59.
33. Babault N, Pousson M, Ballay Y, Van Hoecke J: Activation of human quadriceps femoris during isometric, concentric, and eccentric contractions. J Appl Physiol 2001; 91: 2628-34.
34. Mador MJ, Kufel TJ, Pineda LA, Sharma GK: Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 118-23.
35. Jeffery MM, Kufel TJ, Pineda L: Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 447-53.
36. Mador MJ, Kufel TJ, Pineda LA, Steinwald A, Aggarwal A, Upadhyay AM, Khan MA: Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. Am J Respir Crit Care Med 2001; 163: 930-5.
37. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, Polkey MI, Moxham J: Symptoms and Quadriceps Fatiguability Following Walking and Cycling in COPD. Am J Respir Crit Care Med 2003; 168: 562-7.
38. Serres I, Gautier V, Varray A, Prefaut C: Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998; 113: 900-5.
39. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ: Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-7.
40. Gallagher CG: Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med 1994; 15: 305-26.
41. Leyenson V, Furukawa S, Kuzma AM, Cordova F, Travaline J, Criner GJ: Correlation of changes in quality of life after lung volume reduction surgery with changes in lung function, exercise, and gas exchange. Chest 2000; 118: 728-35.
42. Criner GJ, Cordova FC, Furukawa S, Kuzma AM, Travaline JM, Leyenson V, O'Brien GM: Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 2018-27.
43. 2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1876-82.
44. Ikeda A, Nishimura K, Koyama H, Sugiura N, Izumi T: Oxitropium bromide improves exercise performance in patients with COPD. Chest 1994; 106: 1740-5.
45. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Rev Ed) 1982; 284: 1607-8.
46. No author. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7.
47. Troosters T, Vilaro J, Rabinovich RA, Casas A, Barbera JA, Rodriguez-Roisin R, Roca J: Physiological responses to six minute walking test in COPD patients. Eur Respir J 2002; 20: 564-9.
48. Pitta F, Wyffels B, Spruit MA, Troosters T, Gosselink R, Decramer M: Determinants of activities of daily living (ADL) in COPD patients-a critical analysis. Am J Respir Crit Care Med 2003; 167: A224.
49. Ringbaek TJ, Broendum E, Hemmingsen L, Lybeck K, Nielsen D, Andersen C, Lange P: Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient! Respir Med 2000; 94: 150-4.
50. Green RH, Singh SJ, Williams J, Morgan MD: A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001; 56: 143-5.
51. Troosters T, Gosselink R, Van Hove P, Derom E, Barch P, Pirnay F, Debruycker F, Smeets F, Neirinck L, Decramer M, and REVALIS study group: Effects of pulmonary rehabilitation in a clinical setting. Am J Respir Crit Care Med 2002; 165: A735.
52. Salman GF, Mosier MC, Beasley BW, Calkins DR: Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease. J Gen Intern Med 2003; 18: 213-21.
53. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, Goldstein RS: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002; CD003793.
54. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, Barbera JA, Nadal J, de Jover L, Rodriguez-Roisin R, Wagner PD: Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1726-34.
55. Puente-Maestu L, Sanz ML, Sanz P, Ruiz de Ona JM, Rodriguez-Hermosa JL, Whipp BJ: Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. Eur Respir J 2000; 15: 1026-32.
56. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman. K: Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
57. Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, Carrier L, Belleau R: Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-7.
58. Whittom F, Jobin J, Simard PM, LeBlanc P, Simard C, Bernard S, Belleau R, Maltais F: Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30: 1467-74.
59. Serres I, Varray A, Vallet G, Micallef JP, Prefaut C: Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 1997; 17: 232-8.
60. O'Donnell DE, McGuire M, Samis L, Webb KA: General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am J Respir Crit Care Med 1998; 157: 1489-97.
61. Troosters T, Gosselink R, Decramer M: Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000; 109: 207-12.
62. Spruit MA, Gosselink R, Troosters T, De Paepe C, Decramer M: Resistance versus endurance training in patients with COPD and skeletal muscle weakness. Eur Respir J 2002; 19: 1072-8.
63. Bernard S, Whittom F, LeBlanc P, Jobin J, Belleau R, Berube C, Carrier G, Maltais F: Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 896-901.
64. Ortega F, Toral J, Cejudo P, Villagomez R, Sanchez H, Castillo J, Montemayor T: Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 669-74.
65. O'Donnell DE, McGuire M, Samis L, Webb KA: The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 1995; 152: 2005-13.
66. Couser JI, Guthmann R, Hamadeh MA, Kane CS: Pulmonary rehabilitation improves exercise capacity in elderly. Chest 1995; 107: 730-4.
67. ZuWallack RL, Patel K, Reardon JZ, Clarck BA, Normandin EA: Predictors of improvement in the 12 minute walking distance following a six week out-patient pulmonary rehabilitation program. Chest 1991; 99: 805-8.
68. 2. Am Rev Respir Dis 1988; 138: 1519-23.
69. Troosters T, Gosselink R, Decramer M: Exercise training in COPD; how to distinguish responders from nonresponders. J Cardiopulm Rehabil 2001; 21: 10-7.
70. 2max response to exercise training: results from the HERITAGE family study. J Appl Physiol 1999; 87: 1003-8.
71. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagnet PD: Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 881-5.
72. Coppoolse R, Schols AM, Baarends EM, Mostert R, Akkermans MA, Janssen PP, Wouters EF: Interval versus continuous training in patients with severe COPD: a randomized clinical trial. Eur Respir J 1999; 14: 258-63.
73. Vogiatzis I, Nanas S, Roussos C: Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J 2002; 20: 12-9.
74. Gosselink R, Troosters T, Decramer M: Effects of exercise training in COPD patients; interval versus endurance training. Eur Respir J 1998; 12: 2S.
75. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, De Suso JM, Vilaro J, Barbera JA, Polo MF, Argiles JM, Fernandez-Checa JC, Roca J: Reduced Muscle Redox Capacity after Endurance Training in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 164: 1114-8.
76. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, LeBlanc P, Prefaut C: Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1664-9.
77. Rabinovich RA, Figueras M, Ardite E, Carbó N, Troosters T, Filella X, Barbera JA, Fernandez-Checa JC, Argiles JM, Roca J: Increased TN-Falfa plasma levels during moderate intensity exercise in COPD patients. Eur Respir J 2003; 21: 789-94.
78. Allaire J, Maltais F, LeBlanc P, Simard PM, Whittom F, Doyon JF, Simard C, Jobin J: Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 2002; 25: 383-9.
79. Rabinovich RA, Mayer AM, Ardite E, Vilaro J, Barbera JA, Rodriguez-Roisin R, Fernandez-Checa JC, Roca J: Skeletal muscle redox capacity is reduced in COPD patients with low BMI. Am J Respir Crit Care Med 2003; 167: A124.
80. Koechlin C, Couillard A, Simar D, Chanez P, Bellet M, Cristol JP, Prefaut C: Is oxidative stress implicated in reduced exercise tolerance in COPD. Am J Respir Crit Care Med 2003; 167: A28.
81. van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Schade E: Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54: 287-93.
82. Bergs D: «The Hidden Client»-women caring for husbands with COPD: their experience of quality of life. J Clin Nurs 2002; 11: 613-21.
83. Young P, Dewse M, Fergusson W, Kolbe J: Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. Eur Respir J 1999; 13: 855-9.
84. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P: Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-44.
85. Schols AM, Slangen J, Volovics L, Wouters EF: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-7.
86. Solway S, Brooks D, Lau L, Goldstein R: The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest 2002; 122: 56-65.
87. Probst V, Heyvaert H, Coosemans I, Pitta F, Spruit M, Troosters T, Gosselink R, Decramer M: Effects of a rollator on exercise capacity, gas exchange and ventilation in COPD patients. Am J Respir Crit Care Med 2003; 167: A669.
88. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RS, Cooper CB: Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541-51.
89. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP: Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585-91.
90. Emery CF, Schein RL, Hauck ER, MacIntyre NR: Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998; 17: 232-40.